How many times have I read someone in HC attacking the AFR as being fake news... only for their claims to be 100% correct? The reports by AFR on the dodgy dealings of former company(now defunct) BIG comes to mind.
Anyways it is pretty clear A2M *would* seek to get FDA approval (why wouldn't they?) but the only question is why it's taken them so long.
A2M Price at posting:
$4.90 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)